I honestly think that University facilities ought to open up ‘safely’ for Covid 
related research and diagnostics

Get Outlook for iOS<https://aka.ms/o0ukef>
________________________________
From: CCP4 bulletin board <[email protected]> on behalf of Frank von Delft 
<[email protected]>
Sent: Thursday, April 2, 2020 10:10:03 AM
To: [email protected] <[email protected]>
Subject: Re: [ccp4bb] COVID-19 protease inhibitors - 2nd call for designs - 
Thurs midnight

Hi Nick - it is we that thank you all; and apologies for the tight deadlines, 
all I can say is we'd be a bit more thoughtful but CoV-2 is not being 
particularly obliging either...

There will be at least one more round, deadline approximately one week later;  
and we may have additional fragments because Diamond came back up this week, 
just for COVID work.

Speaking of which:  reminder that if you need a synchrotron or cryoEM for COVID 
work, you can put in rapid access proposals - details on Diamond's website.

(I'll stop spamming the list now - thanks for your forebearance.)

Frank



On 02/04/2020 01:01, Nicholas Larsen wrote:
Hi Frank, I thought we were working quickly, but we only just got all of your 
structures uploaded in our Proasis system today and can only now begin analysis 
and design ideas.  I don't know if we will have much of anything by your 
deadline.  Will there be additional design rounds?  Thanks again for making all 
this data available and it really is inspirational what your team is doing to 
confront collaboratively this global crisis.
Best,
Nick

On Wed, Apr 1, 2020 at 10:16 AM Frank von Delft 
<[email protected]<mailto:[email protected]>> wrote:
All - last week's call for compound designs to the CoV-2 main protease 
(https://covid.postera.ai/covid)
elicited an astonishing response...  (I confess I was quite taken aback.)

I just realised I should let this BB know the second call for designs is now 
open.  Deadline is tomorrow 23:59 PST (April 2nd).  (Apologies for those that 
weren't following on twitter.)

Two things:

  *   we're asking for designs especially focusing on covalent inhibitors (read 
more 
here<https://discuss.postera.ai/t/screening-cascade-fast-track-and-regular-track-of-designs/567>)
  *   the most convincing designs will be fast-tracked by spending more money 
to cut several weeks off the testing (read more 
here<https://discuss.postera.ai/t/screening-cascade-fast-track-and-regular-track-of-designs/567>)

Happy designing!

Frank

________________________________

To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1

[This e-mail message may contain privileged, confidential and/or proprietary 
information of H3 Biomedicine. If you believe that it has been sent to you in 
error, please contact the sender immediately and delete the message including 
any attachments, without copying, using, or distributing any of the information 
contained therein. This e-mail message should not be interpreted to include a 
digital or electronic signature that can be used to authenticate an agreement, 
contract or other legal document, nor to reflect an intention to be bound to 
any legally-binding agreement or contract.]


________________________________

To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1

########################################################################

To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1

Reply via email to